Evidence map›Paper›PMID 33356566›Full record

ArticleFuture oncology (London, England)2021

Novel CD33 antibodies unravel localization, biology and therapeutic implications of CD33 isoforms.

Mohammed O Gbadamosi, Vivek M Shastri, Tiffany Hylkema, Ioannis Papageorgiou, Laura Pardo, Christopher R Cogle, Andria Doty, Michael R Loken, Soheil Meshinchi, Jatinder K Lamba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammed O GbadamosiDepartment of Pharmacotherapy & Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Vivek M ShastriDepartment of Pharmacotherapy & Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Tiffany HylkemaClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Ioannis PapageorgiouDepartment of Pharmacotherapy & Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Laura PardoHematologics Inc., Seattle, WA 98121, USA.
Christopher R CogleDepartment of Hematology/Oncology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Andria DotyInterdisciplinary Center for Biotechnology Flow Cytometry & Imaging Core, University of Florida, Gainesville, FL 32610, USA.
Michael R LokenHematologics Inc., Seattle, WA 98121, USA.
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Jatinder K LambaDepartment of Pharmacotherapy & Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.ORCID https://orcid.org/0000-0003-0411-0007

Funding

CHARACTERIZATION OF THE PATHOGENESIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM)Z01HL002541 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MOSS, JOEL · 1996 to 2008
$4.5M
Intramural NIH HHS Z01 HL002541
6 · The paper itself

Abstract

The aim of this study was to establish the therapeutic relevance of the CD33

Indexed as

AdolescentAnimalsAntibodies, MonoclonalBone Marrow CellsCell Line, TumorChildChild, PreschoolFemaleGenotypeHumansImmunoglobulin DomainsInfantLeukemia, Myeloid, AcuteMaleMiceProtein IsoformsAntibodies, MonoclonalCD33 protein, humanProtein IsoformsSialic Acid Binding Ig-like Lectin 3acute myeloid leukemiaantibodiesCD33immunotargetimmunotherapy

Identifiers

PMID33356566
PMCPMC10621775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.